BIANCONI, FORTUNATO
 Distribuzione geografica
Continente #
NA - Nord America 3.563
EU - Europa 2.593
AS - Asia 2.273
SA - Sud America 406
Continente sconosciuto - Info sul continente non disponibili 220
AF - Africa 74
OC - Oceania 6
Totale 9.135
Nazione #
US - Stati Uniti d'America 3.475
SG - Singapore 1.040
IT - Italia 517
IE - Irlanda 509
CN - Cina 334
BR - Brasile 312
HK - Hong Kong 302
UA - Ucraina 301
RU - Federazione Russa 299
SE - Svezia 245
VN - Vietnam 224
DE - Germania 183
FR - Francia 152
FI - Finlandia 134
GB - Regno Unito 99
KR - Corea 75
BD - Bangladesh 63
IN - India 51
CA - Canada 40
IQ - Iraq 31
TR - Turchia 31
AR - Argentina 30
AT - Austria 23
RO - Romania 23
PL - Polonia 22
JP - Giappone 20
MX - Messico 20
ZA - Sudafrica 18
NL - Olanda 16
CH - Svizzera 14
EC - Ecuador 14
BE - Belgio 13
ID - Indonesia 13
VE - Venezuela 13
PK - Pakistan 12
CO - Colombia 11
MA - Marocco 11
UZ - Uzbekistan 11
TN - Tunisia 10
BO - Bolivia 9
LB - Libano 9
PH - Filippine 9
CR - Costa Rica 8
ES - Italia 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
EG - Egitto 7
OM - Oman 7
GR - Grecia 6
KE - Kenya 6
PY - Paraguay 6
SN - Senegal 6
AL - Albania 5
AU - Australia 5
CL - Cile 5
JM - Giamaica 5
JO - Giordania 5
NP - Nepal 5
ET - Etiopia 4
HN - Honduras 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
BA - Bosnia-Erzegovina 3
DZ - Algeria 3
IL - Israele 3
KZ - Kazakistan 3
MY - Malesia 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EU - Europa 2
GT - Guatemala 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
CD - Congo 1
CM - Camerun 1
CV - Capo Verde 1
DJ - Gibuti 1
KG - Kirghizistan 1
KW - Kuwait 1
MK - Macedonia 1
MM - Myanmar 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RE - Reunion 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 8.916
Città #
Singapore 710
Chandler 528
Dublin 509
Hong Kong 300
San Jose 286
San Mateo 210
Ashburn 192
Perugia 178
Jacksonville 156
Santa Clara 155
Boardman 140
Moscow 104
Medford 98
Princeton 98
Ann Arbor 97
Beijing 96
Lauterbourg 85
Andover 84
Wilmington 77
Dong Ket 75
Seoul 75
Munich 60
Altamura 59
Lawrence 58
Los Angeles 53
Ho Chi Minh City 51
New York 48
Helsinki 37
The Dalles 36
Des Moines 35
São Paulo 33
Hanoi 31
Houston 30
Dallas 28
Redwood City 27
Saint Petersburg 25
Phoenix 23
Bucharest 21
Norwalk 20
Woodbridge 20
Piscataway 19
Tokyo 19
Brooklyn 17
Frankfurt am Main 17
Chennai 16
Chicago 16
Montreal 16
Redmond 16
Rome 16
Turku 16
Falkenstein 15
Nuremberg 15
Warsaw 15
Milan 14
Orem 14
Atlanta 13
Brussels 13
Mexico City 13
Coccaglio 12
Johannesburg 12
London 12
Poplar 11
San Mauro Pascoli 11
Stockholm 11
Caracas 10
Izmir 10
Baghdad 9
Dearborn 9
Denver 9
Rio de Janeiro 9
San Paolo di Civitate 9
Terni 9
Vienna 9
Den Haag 8
Haiphong 8
Shanghai 8
Toronto 8
Council Bluffs 7
Guangzhou 7
San José 7
Da Nang 6
Dakar 6
Dhaka 6
Falls Church 6
Guayaquil 6
Istanbul 6
Manchester 6
Marsciano 6
New Delhi 6
Quito 6
Tashkent 6
Tunis 6
Amman 5
Amsterdam 5
Ankara 5
Bologna 5
Boston 5
Brasília 5
Buffalo 5
Curitiba 5
Totale 5.545
Nome #
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 193
An Application of Conditional Robust Calibration (CRC) to The Lotka-Volterra Predator-Prey model in computational systems biology: a comparison of two sampling strategies 176
Cancer Registry and information technology: a new management system for integrating Cancer Registry and Oncology Departments 158
I Tumori multipli in Umbria. 133
Prognostic Role of Erbb Family Receptors, Myc and Mitogen-activated Protein Kinase (mapk) In Patients With Early-stage Non Small-cell Lung Cancer 131
Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis 130
Partecipazione al IV round dello screening citologico nella AUSL 2 dell’Umbria. 128
Incidence of multiple primary cancers following respiratory tract cancer in Umbria, Italy. 126
Significato prognostico dell’espressione immunoistochimica di Insulin like growth facor receptor 1 (IGFR-1) ed epidermal growth factor receptor (EGFR) nei carcinomi non a piccole cellule del polmone (NSCLC). 125
A New Bayesian Methodology for Nonlinear Model Calibration in Computational Systems Biology 123
P-126 * PROGNOSTIC SIGNIFICANCE OF MYC AND HUMAN TELOMERASE GENE AMPLIFICATION IN SURGICALLY TREATED EARLY STAGE NON-SMALL CELL LUNG CANCER 122
Cancer incidence in Italian contaminated sites 121
A Hybrid Model of Nucleotide Excision Repair in Neoplastic Diseases: The Identification Problem. 120
A machine learning approach applied to Reverse Phase Protein Microarray data for pathways activation mapping of KRAS wild type and mutated adenocarcinomas of the lung 120
Effectiveness and predictability of pleurodesis with the Tachosil® surgical patch compared with talc poudrage: An experimental study 120
Cancer burden trends in Umbria region using a joinpoint regression 115
MYC and Human Telomerase Gene (TERC) Copy Number Gain in Early-stage Non-small Cell Lung Cancer 114
Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer 111
Spatial barriers impact upon appropriate delivery of radiotherapy in breast cancer patients 111
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations. 110
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients 108
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 108
A Hybrid Model of Nucleotide Excision Repair in Neoplastic diseases and in vitro Experiments 107
Robust Calibration of High Dimension Nonlinear Dynamical Models for Omics Data: An Application in Cancer Systems Biology 105
Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcome in Resected Non-Small Cell Lung Cancer Patients 104
EPIDEMIOLOGIA DEL CANCRO DELL'ENDOMETRIO IN UMBRIA 104
Information technology as tools for Cancer Registry and Regional Cancer Network integration 103
An approach for optimally extending mathematical models of signaling networks using omics data 103
I tumori della tiroide 99
I tumori dell'ovaio. 99
An approach to the conditional robustness problem for biochemical networks 99
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma 98
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study 98
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients 98
Come misurare “l’impatto” dello screening colorettale nella Regione Umbria 97
Effect of healthcare on mortality: trends in avoidable mortality in Umbria, Italy, 1994-2009 97
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free servival in resected non-small-cell lung cancer patients. 96
Registro Tumori, tecnologia informatica e rete oncologica regionale. Integrazione tra Registro Tumori e Servizi oncologici in Umbria. 95
Espressione dei recettori HER nei carcinomi non a piccole cellule del polmone 94
Computational model of EGFR and IGF1R pathways in lung cancer: A Systems Biology approach for Translational Oncology 94
Screening for colorectal cancer in Italy: 2011-2012 survey 93
Regional indices of socio-economic and health inequalities: a tool for public health programming 93
A strategy for parameter estimation for mRNA and protein dynamics 92
Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC). 92
I tumori del rene 91
Modelli dinamici per lo studio dei meccanismi di riparo del danno al DNA 90
High coexpression of both insulin-like growth factor receptor 1 (igfr-1) and epidermal growth factor receptor (egfr) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients 90
THE EVOLVING ROLE OF CANCER REGISTRY: INFORMATION TECHNOLOGY AS TOOL FOR INTEGRATION WITH ONCOLOGY DEPARTMENTS 89
Cancer registry integration in the Umbria Regional Cancer Network: breast cancer as a model to build a supportive information system. 89
EGFR, KRAS, PIK3CA mutations and response to tyrosine kinase inhibitors (TKIs) in advanced NSCLC patients. 88
I tumori delle alte vie aero-digestive. 88
Seasonality of birth for skin melanoma deserves further investigation 87
Staging, missing prognostic information and colorectal cancer control in Umbria 85
Linking surgical specimen length and examined lymph nodes in colorectal cancer patients 84
Prognostic implications of epidermal growth factor receptor, KRAS and BRAF gene mutations in resected non-small cell lung cancer patients 84
Dynamic network topologies analysis in proteomics data of NSCLC cell lines using a new pipeline based on machine learning tools 84
Geographical suite for web management system of cancer registries 83
Numeri dell'AIRTUM: 2000 giovani italiani vivono con il cancro. 83
Computational model of EGFR and IGF1R pathways in lung cancer: A Systems Biology approach for Translational Oncology (vol 30, pg 142, 2012) 83
Stadio alla diagnosi e controllo del cancro del grosso intestino in Umbria. 82
I tumori del pene e del testicolo. 82
La geografia del cancro in Umbria: incidenza 1978-2008. 82
Epidemiology of HPV-related female cancers in the Umbria region of Italy: Pre-vaccination period 81
Registro Tumori, tecnologia informatica e rete oncologica regionale: integrazione tra Registro Tumori e Servizi oncologici in Umbria. XIII Riunione annuale AIRTum. 80
Use of Electronic Administrative Databases to Measure Quality Indicators of Breast Cancer Care: Experience of Five Regional Oncology Networks in Italy 80
Trend di incidenza e mortalità per cancro negli anziani in Umbria. 78
Clinical significances of ErbB family receptors, Myc, and mitogen-activated protein kinase (MAPK) in patients with early-stage non-small cell lung cancer. 78
Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology 78
Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients. 78
Systems biology in personalized medicine in oncology: A case study in non-small cell lung cancer 77
Prevalence and spectrum of brca germline variants in central Italian high risk or familial breast/ovarian cancer patients: A monocentric study 76
Narrative Medicine in Amyotrophic Lateral Sclerosis and a Rehabilitation Project Based on International Classification of Functioning, Disability and Health 75
I tumori della vescica. 75
Dynamic modeling and parameter identification for biological networks: application to the DNA damage and repair processes 74
Dynamic modeling, parameter estimation and experiment design in Systems Biology with applications to Oncology 72
Trends in invasive and in situ (CIN 3) cervical cancer incidence and mortality in Umbria, Italy: 1994-2008 72
Role of Expression Levels of Fabp3, H19, Tfpi2, Ark1b1 Cyp3a5, Scgb3a2 Genes In Adenocarcinoma Stage I Patients. 71
I tumori in Italia, rapporto 2011. La sopravvivenza dei pazienti oncologici in Italia. 70
Cancer and Pregnancy: Estimates in Italy from Record-Linkage Procedures between Cancer Registries and the Hospital Discharge Database 68
Gruppo multidisciplinare regionale per le neoplasie tiroidee, registro tumori e tecnologia informatica: integrazione tra registro tumori e specialisti di oncologia tiroidea in Umbria. 67
What has changed in the epidemiology of skin melanoma in central Italy during the past 20 years? 66
Envelope stress response in E.Coli: computational model 65
I numeri di AIRTUM: Buone notizie per i bambini italiani. Dopo il 2000 si arresta anche la crescita dei tumori maligni del sistema nervoso centrale. 65
INSULIN-LIKE GROWTH FACTOR RECEPTOR 1 (IGF1R) AND EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFICATION AND EXPRESSION IN SURGICALLY RESECTED NSCLC 65
Systems Biology and translational oncology: a case study of predictive modeling in molecular biology of the lung cancer 63
Robustness of complex feedback systems: application to oncological biochemical networks 63
Seasonal variation in the month of birth in patients with skin cancer 63
MYC and human telomerase (TERC) gene copy number gain in resected non-small cell lung cancer (NSCLC) 62
KRAS gene mutation testing an inter-laboratory validated workflow for quality assured, clinical-grade results using capillary electrophoresis. 61
SYSTEMS BIOLOGY IN TRANSLATIONAL ONCOLOGY: COMPUTATIONAL AND EXPERIMENTAL STUDY OF EGFR AND IGF1R PATHWAYS IN NSCLC CELL LINES 60
Genome-wide expression of the residual lung reacting to experimental Pneumonectomy 59
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. 58
Espressione dei recettori Her nei carcinomi non a piccole cellule del polmone. 57
Trend di mortalità per cause in Umbria. 1994-2010 57
Prognostic Role of Expression Levels of Fabp3, H19, Tfpi2, Akr1b10 Cyp3a5, Scgb3a2 Genes In Adenocarcinoma Stage I Patients 55
Prognostic role of expression levels of FABP3 and AKR1B10 genes in adenocarcinoma stage I patients. 52
Influence of geographic barriers and care pathways on radiotherapy treatment and survival of breast cancer patients 52
Trend d’incidenza delle lesioni cervicali in situ ed infiltranti in Umbria. 51
PROGNOSTIC AND PREDICTIVE ROLE OF PIK3CA MUTATIONS IN NON SMALL CELL LUNG CANCER PATIENTS TREATED WITH EGFR TYROSINE KINASE INHIBITORS (TKIS) 47
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of MET, EGFR, KRAS, and PIK3CA mutations. 43
Totale 9.021
Categoria #
all - tutte 42.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.581


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022666 0 0 9 47 12 5 13 288 29 27 93 143
2022/20231.601 109 249 33 127 127 170 0 73 650 2 54 7
2023/2024600 35 54 27 23 4 5 151 26 66 16 107 86
2024/20251.279 33 121 106 34 157 62 41 99 235 72 207 112
2025/20262.974 211 190 159 412 440 248 462 142 299 271 99 41
2026/2027133 46 74 13 0 0 0 0 0 0 0 0 0
Totale 9.135